107 related articles for article (PubMed ID: 8743610)
1. Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats.
Garrett BE; Holtzman SG
Pharmacol Biochem Behav; 1996 Jun; 54(2):469-77. PubMed ID: 8743610
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
Gancher S; Mayer A
Brain Res; 1995 Jun; 682(1-2):63-8. PubMed ID: 7552328
[TBL] [Abstract][Full Text] [Related]
3. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
4. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
5. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
6. Lack of synergism between caffeine and SKF 38393 on rotational behavior in 6-hydroxydopamine-denervated rats.
Casas M; Prat G; Rubio A; Barbanoj M; Jané F
Eur J Pharmacol; 2000 May; 396(2-3):93-9. PubMed ID: 10822061
[TBL] [Abstract][Full Text] [Related]
7. Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
Popoli P; Reggio R; Pèzzola A
Neuropsychopharmacology; 2000 May; 22(5):522-9. PubMed ID: 10731627
[TBL] [Abstract][Full Text] [Related]
8. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
[TBL] [Abstract][Full Text] [Related]
9. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
10. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
11. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
Dalia A; Uretsky NJ; Wallace LJ
Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
[TBL] [Abstract][Full Text] [Related]
14. A comparison of two behavioral measures of psychomotor activation following intravenous amphetamine or cocaine: dose- and sensitization-dependent changes.
Crombag HS; Mueller H; Browman KE; Badiani A; Robinson TE
Behav Pharmacol; 1999 Mar; 10(2):205-13. PubMed ID: 10780833
[TBL] [Abstract][Full Text] [Related]
15. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
16. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
17. The effects of dopamine agonists on rotational behavior in non-tolerant and caffeine-tolerant rats.
Garrett BE; Holtzman SG
Behav Pharmacol; 1995 Dec; 6(8):843-851. PubMed ID: 11224389
[TBL] [Abstract][Full Text] [Related]
18. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
19. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
[TBL] [Abstract][Full Text] [Related]
20. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
Garrett BE; Holtzman SG
Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
